Immune Checkpoint Series

Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
Bingxi He, Di Dong, Yunlang She, Caicun Zhou, Mengjie Fang, Yongbei Zhu, Henghui Zhang, Zhipei Huang, Tao Jiang, Jie Tian, Chang Chen

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000550; DOI: 10.1136/jitc-2020-000550
On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
Thilo Gambichler, Judith Reuther, Christina H Scheel, Jürgen Christian Becker

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e001145; DOI: 10.1136/jitc-2020-001145
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study
Xue Bai, De-Hua Wu, Si-Cong Ma, Jian Wang, Xin-Ran Tang, Shuai Kang, Qiang John Fu, Chuan-Hui Cao, He-San Luo, Yu-Han Chen, Hong-Bo Zhu, Hong-Hong Yan, Yi-Long Wu, Zhong-Yi Dong

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000381; DOI: 10.1136/jitc-2019-000381
Tim-3 finds its place in the cancer immunotherapy landscape
Nandini Acharya, Catherine Sabatos-Peyton, Ana Carrizosa Anderson

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000911; DOI: 10.1136/jitc-2020-000911
Immune checkpoint inhibitor-associated celiac disease
Yousef R Badran, Angela Shih, Donna Leet, Meghan J Mooradian, Alexandra Coromilas, Jonathan Chen, Marina Kem, Hui Zheng, Jennifer Borowsky, Joseph Misdraji, Mari Mino-Kenudson, Michael Dougan

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000958; DOI: 10.1136/jitc-2020-000958
MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy
Xiaoyu Jiang, Stephanie Dudzinski, Kathryn E Beckermann, Kirsten Young, Eliot McKinley, J Oliver McIntyre, Jeffrey C Rathmell, Junzhong Xu, John C Gore

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000328; DOI: 10.1136/jitc-2019-000328
Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies
Lambros Tselikas, Thierry de Baere, Thomas Isoardo, Sandrine Susini, Karine Ser-Le Roux, Mélanie Polrot, Julien Adam, Mathieu Rouanne, Laurence Zitvogel, Laurence Moine, Fréderic Deschamps, Aurélien Marabelle

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000579; DOI: 10.1136/jitc-2020-000579
Lifting the innate immune barriers to antitumor immunity
Carla V Rothlin, Sourav Ghosh

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000695; DOI: 10.1136/jitc-2020-000695
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, Eric Vivier

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 263; DOI: 10.1186/s40425-019-0761-3

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immune Checkpoint Series